latest update:
[TrialBase DB]

trial summary · NCT07870967

Undenatured Type II Collagen for Knee Osteoarthritis Pain

Randomized Clinical Trial to Analyze the Efficacy and Safety of Undenatured Type II Collagen Product on Joint Pain in Patients Diagnosed With Osteoarthritis

Trial record from the TrialBase DB dataset, status RECRUITING, condition Osteoarthritis, Knee, sponsored by Universidad Católica San Antonio de Murcia. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07870967phase —enrollment 120start 2027-03

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

This randomized, controlled, double-blind, three-arm parallel clinical trial will evaluate the efficacy and safety of undenatured type II collagen products on joint pain in adults diagnosed with knee osteoarthritis. Participants will be randomized to Nuvicol II (nuvicol® II), Nuvicol SII (nuvicol® S II), or placebo and will consume one capsule daily for 4 months. Pain, quality of life, knee muscle function, concomitant analgesic medication use, cartilage degradation biomarkers, safety laboratory variables, and adverse events will be assessed during follow-up.

Source record: https://clinicaltrials.gov/study/NCT07870967

Facts

registry idNCT07870967
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasenot reported
study typeINTERVENTIONAL
lead conditionOsteoarthritis, Knee
sponsorUniversidad Católica San Antonio de Murcia
sponsor classOTHER
enrollment120
start date2027-03
primary completion2027-07
completion2027-07
results postednot reported

Conditions

  • Osteoarthritis, Knee

Interventions

  • Placebo
  • Nuvicol II
  • Nuvicol SII

Countries

  • Spain

Intervention types: DIETARY_SUPPLEMENT

Work with this record